Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
In chemotherapy-treated breast cancer, wild-type p53 preferentially induces senescence over apoptosis, resulting in a persisting cell population constituting residual disease that drives relapse and poor patient survival via the senescence-associated secretory phenotype. Understanding the properties of tumor cells that allow survival after chemotherapy treatment is paramount. Using time-lapse and confocal microscopy to observe interactions of cells in treated tumors, we show here that chemotherapy-induced senescent cells frequently engulf both neighboring senescent or nonsenescent tumor cells at a remarkable frequency. Engulfed cells are processed through the lysosome and broken down, and cells that have engulfed others obtain a survival advantage. Gene expression analysis showed a marked up-regulation of conserved macrophage-like program of engulfment in chemotherapy-induced senescent cell lines and tumors. Our data suggest compelling explanations for how senescent cells persist in dormancy, how they manage the metabolically expensive process of cytokine production that drives relapse in those tumors that respond the worst, and a function for their expanded lysosomal compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although still poorly understood, chemotherapy-resistant senescent cells can engulf neighboring normal and tumor cells by phagocytosis for survival advantage [229].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Real-time PCR was performed on a QuantStudio6 (Applied Biosystems) using Sybr Green (Bio-Rad) and analysis as per Pfaffl (2001), as previously described (Jackson et al., 2012).”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · cited 2×
“…senescent cells process engulfed cells to the lysosome Senescent cells have a vastly expanded lysosomal compartment that is detected by the SA-βGAL assay (Kurz et al., 2000; Lee et al., 2006), which is used widely as a marker for senescence (Dimri et al., 1995; Sharpless and Sherr, 2015).”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 3×
“, 2006), is a well-described feature of many senescent cell types, both in vivo and in vitro, in normal and cancer cells (Jackson et al., 2012; Sharpless and Sherr, 2015), including chemotherapytreated breast cancers (te Poele et al.”
BackgroundInfluentialDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“TP53 mutant cells are more sensitive to DNA damage (Brown and Wouters, 1999; Bunz et al., 1999), but cells that survive can undergo p53-independent senescence in culture (Chang et al.”
BackgroundKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
Research works printed but not linked: 1
- Tonnessen-Murray C., Lozano G., and Jackson J.G. 2016 The p53 Protein: From Cell Regulation to Cancer. In Lozano G., and Levine A.J., editors. The p53 Protein: From Cell Regulation to Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 173– 186.
Cited by
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Indeed, upon engulfment and processing through lysosomes of these cells, biosynthetic material and energy are released to sustain the high metabolic needs of senescent cells [229].”
BackgroundPersistent Cancer Cells: The Deadly Survivors
Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Shahbandi, A., Nguyen, H. D., & Jackson, J. G. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.007 · Cited by 226
Self-citationClassical and Nonclassical Intercellular Communication in Senescence and Ageing
Fafián-Labora, J. A., & O’Loghlen, A. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.003 · Cited by 228
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Cui, C., Yang, J., Li, X., Liu, D., Fu, L., & Wang, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01180-y · Cited by 206
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
Chambers, C. R., Ritchie, S., Pereira, B. A., & Timpson, P. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13042 · Cited by 165
“For example, Tonnessen-Murray et al. (2019) reported that breast cancer cells rendered senescent with doxorubicin (Dox) treatment can completely engulf neighbouring cells via a phagocytosis-like phenomenon to aid their survival [49].”
BackgroundSimilarities and interplay between senescent cells and macrophages
Behmoaras, J., & Gil, J. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202010162 · Cited by 158
“SASP can also lead to an antitumor immune response through recruitment of immune cells (Rao and Jackson, 2016; Toso et al., 2014).”
BackgroundNeutrophils in aging and aging‐related pathologies
Avondt, K. V., Strecker, J., Tulotta, C., Minnerup, J., Schulz, C., & Soehnlein, O. (2022) · Immunological Reviews · doi:10.1111/imr.13153 · Cited by 165
Shahbandi, A., Rao, S. G., Anderson, A. Y., Frey, W. D., Olayiwola, J. O., Ungerleider, N., & Jackson, J. G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0564-6 · Cited by 143
Self-citationBrown, G. C. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00921-6 · Cited by 129
“Senescent cancer cells apparently can become highly phagocytic and phagocytose neighbouring cells alive, resulting in cell death by phagocytosis 139 .”
Senescent cells and macrophages: key players for regeneration?
Elder, S. S., & Emmerson, E. (2020) · Open Biology · doi:10.1098/rsob.200309 · Cited by 117
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
“Similarly, p53 wild type breast tumor cells induced to senescence with doxorubicin activate phagocytosis and macrophage-like programs promoting a higher survival capacity during long dormancy periods after engulfing proliferative neighbors [196].”
BackgroundCellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 92
Shahbandi, A., Chiu, F.-Y., Ungerleider, N. A., Kvadas, R., Mheidly, Z., Sun, M. J. S., Tian, D., Waizman, D. A., Anderson, A. Y., Machado, H. L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00466-y · Cited by 83
Self-citationPrognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
Flynt, E., Bisht, K. K., Sridharan, V., Ortiz, M., Towfic, F., & Thakurta, A. (2020) · Cells · doi:10.3390/cells9020287 · Cited by 85
Targeting tumor cell senescence and polyploidy as potential therapeutic strategies
Saleh, T., Carpenter, V. J., Bloukh, S., & Gewirtz, D. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.010 · Cited by 74
Shin, J. H., Jeong, J., Maher, S. E., Lee, H., Lim, J., & Bothwell, A. L. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110241118 · Cited by 77
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse
Manjili, S. H., Isbell, M., Ghochaghi, N., Perkinson, T., & Manjili, M. H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.023 · Cited by 63
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
Gutwillig, A., Santana-Magal, N., Farhat-Younis, L., Rasoulouniriana, D., Madi, A., Luxenburg, C., Cohen, J., Padmanabhan, K., Shomron, N., Shapira, G., et al. (2022) · eLife · doi:10.7554/elife.80315 · Cited by 62
Li, X., Zhong, Y., Zhang, X., Sood, A. K., & Liu, J. (2023) · Oncogene · doi:10.1038/s41388-022-02588-0 · Cited by 60
“Other groups have also observed cell-in-cell formation [41, 54] and chemotherapy-induced senescent cancer cells engulfing other cells [55].”
BackgroundMing, X., Yang, Z. R., Huang, Y., Wang, Z., Zhang, Q., Lu, C., Sun, Y., Chen, Y., Zhang, L., Wu, J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00750-9 · Cited by 61
“Senescent cells in the chemotherapy-induced tumor microenvironment may facilitate tumor growth and metastasis via the SASP 45–47 .”
Subcellular structure, heterogeneity, and plasticity of senescent cells
Bitencourt, T. C., Vargas, J. E., Silva, A. O., Fraga, L. R., & Filippi‐Chiela, E. (2024) · Aging Cell · doi:10.1111/acel.14154 · Cited by 46
“Finally, SnCs acquire the capacity to engulf neighboring cells and degrade them by lysosomal activity, a process that may contribute to SnC survival (Tonnessen-Murray et al., 2019 ).”
BackgroundClassification of Cell-in-Cell Structures: Different Phenomena with Similar Appearance
Borensztejn, K., Tyrna, P., Gaweł, A. M., Dziuba, I., Wójcik, C., Biały, Ł. P., & Młynarczuk-Biały, I. (2021) · Cells · doi:10.3390/cells10102569 · Cited by 53
“, MCF7) that outer cannibalistic cells display a higher survival rate than other cells [36].”
BackgroundLee, D. H., Imran, M., Choi, J. H., Park, Y. J., Kim, Y. H., Min, S., Park, T. J., & Choi, Y. W. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13541 · Cited by 48
Cell Death by Entosis: Triggers, Molecular Mechanisms and Clinical Significance
Kianfar, M., Balcerak, A., Chmielarczyk, M., Tarnowski, L. J., & Grzybowska, E. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094985 · Cited by 46
TRAIL signaling promotes entosis in colorectal cancer
Bozkurt, E., Düßmann, H., Salvucci, M., Cavanagh, B., Schaeybroeck, S. V., Longley, D. B., Martin, S. J., & Prehn, J. H. M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202010030 · Cited by 43
Insights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 40
“Cannibalism MCF-7 cells exposed to doxorubicin [80]”
Cell-in-Cell–Mediated Entosis Reveals a Progressive Mechanism in Pancreatic Cancer
Song, J., Xu, R., Zhang, H., Xue, X., Ruze, R., Chen, Y., Yin, X., Wang, C., & Zhao, Y. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.08.035 · Cited by 40
Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance
Melcher, V., Graf, M., Interlandi, M., Moreno, N., de Faria, F. W., Kim, S. N., Kastrati, D., Korbanka, S., Alfert, A., Gerß, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02116-7 · Cited by 41
“, between MACs and tumor cells, have been linked to therapy resistance, tumor stage and patient survival in other tumors [26, 80, 95], we intended to examine whether the intermediary hybrid-like clusters are associated with chemo-resistance in ATRT.”
BackgroundChaturvedi, P., George, V., Shrestha, N., Wang, M., Dee, M. J., Zhu, X., Liu, B., Egan, J. O., D’Eramo, F., Spanoudis, C. M., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.025 · Cited by 35
Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
An Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404885 · Cited by 32
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazières, J., & Calvayrac, O. (2022) · Cancers · doi:10.3390/cancers14112613 · Cited by 34
Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy
Jaber, S., Warnier, M., Leers, C., Vernier, M., Goehrig, D., Médard, J., Vindrieux, D., Ziegler, D. V., & Bernard, D. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00116-4 · Cited by 29
El‐Sadoni, M., Shboul, S. A., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., Ababneh, N. A., Alotaibi, M. R., Azab, B., & Saleh, T. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04523-w · Cited by 28
“TIS largely contributes to tumor cell fate leading to a stable growth arrest and a wide-range reprogramming that is associated with enhanced migratory and invasive potential [27, 72, 73], cellular cannibalism [74], hypersecretory state [19], and delayed apoptosis [75, 76].”
BackgroundIvanov, V. N., Grabham, P. W., Wu, C., & Hei, T. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59468-4 · Cited by 29
RetractedFibroblasts in cancer dormancy: foe or friend?
Dai, L., Mao, L., Zhang, W., Tang, Y.-J., Tang, Y., & Liang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01883-2 · Cited by 28
“In addition, lysosome, which plays a critical role in senescence, is found to function as a dimmer switch to mediate the quiescence depth in rat embryonic fibroblasts [72, 73].”
BackgroundThe origins of cancer cell dormancy
Morales-Valencia, J., & David, G. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101914 · Cited by 25
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer Treatment
Saleh, T., Greenberg, E. F., Faber, A. C., Harada, H., & Gewirtz, D. A. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2219 · Cited by 32
Olona, A., Hateley, C., Guerrero, A., Ko, J., Johnson, M. R., Anand, P. K., Thomas, D., Gil, J., & Behmoaras, J. V. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15423 · Cited by 24
The premise of personalized immunotherapy for cancer dormancy
Manjili, M. H. (2020) · Oncogene · doi:10.1038/s41388-020-1295-3 · Cited by 28
Zhang, X., Zhang, M., Cui, H., Zhang, T., Wu, L., Xu, C., Yin, C., & Gao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.032 · Cited by 26
Cell-in-Cell Events in Oral Squamous Cell Carcinoma
da Rocha, L. D. O. S., Souza, B. S. D. F., Lambert, D., & Rocha, C. A. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931092 · Cited by 24
“(39); Krajcovic and Overholtzer (40); Bartosh et”
BackgroundLi, K., Liao, N., Chen, B., Zhang, G., Wang, Y., Guo, L., Wei, G., Jia, M., Wen, L., Ren, C., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05778-0 · Cited by 23
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
Allouch, A., Voisin, L., Zhang, Y., Raza, S. Q., Lécluse, Y., Calvo, J., Selimoglu‐Buet, D., de Botton, S., Louache, F., Pflumio, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34548-3 · Cited by 29
ZNF300 promotes chemoresistance and aggressive behaviour in non‐small‐cell lung cancer
Yu, S., Ao, Z., Wu, Y. M., Song, L., Zhang, P., Li, X., Liu, M., Qian, P., Zhang, R., Li, X., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12924 · Cited by 19
Adaptations of membrane trafficking in cancer and tumorigenesis
Evergren, E., Mills, I. G., & Kennedy, G. (2024) · Journal of Cell Science · doi:10.1242/jcs.260943 · Cited by 28
Therapy-induced senescence is finally escapable, what is next?
Saleh, T. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2364579 · Cited by 24
“Furthermore, senescent tumor cells, which frequently exhibit increased levels of autophagy, can overcome metabolic distress and repo-pulate [13,39], often coupled with their ability to cannibalize on neighboring cells [40].”
BackgroundAqbi, H. F., Coleman, C. L., Zarei, M., Manjili, S. H., Graham, L., Koblinski, J. E., Guo, C., Xie, Y., Guruli, G., Bear, H. D., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01357-9 · Cited by 21
Sobeai, H. M. A., Alohaydib, M. H., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Saleh, T., Gewirtz, D. A., & Alotiabi, M. R. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.004 · Cited by 20
Saleh, T., Tyutyunyk‐Massey, L., Patel, N. H., Cudjoe, E. K., Alotaibi, M. R., & Gewirtz, D. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041427 · Cited by 20
“In this regard, a recent publication identified a process of cellular cannibalism as potentially providing the energy necessary for senescent cell survival [51].”
Backgroundden Bossche, J. V., Domen, A., Peeters, M., Deben, C., Pauw, I. D., Jacobs, J., Bruycker, S. D., Specenier, P. M., Pauwels, P., Vermorken, J. B., et al. (2019) · Cancers · doi:10.3390/cancers11121893 · Cited by 20
“These results are in line with other studies investigating the importance of p53 in the modulation of cellular senescence in cancer cells [43,44,46,54].”
ResultFeng, D., Shi, X., You, J., Xiong, Q., Zhu, W., Wei, Q., & Yang, L. (2022) · PubMed · Cited by 20
Demir, Y. D. Ş., Özdemir, A., Sucularlı, C., Benhür, E., & Ark, M. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110007 · Cited by 18
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
“Indeed, lymphomas that entered TIS upon ADR or palbo exposure, but not equally treated Suv39h1-de fi cient lymphomas, displayed profound respiratory burst activity, reminiscent of monocytoid cells able to engulf neighboring cells 59 (Fig.”
Tóth, F., Moftakhar, Z., Sotgia, F., & Lisanti, M. P. (2024) · Cells · doi:10.3390/cells13100841 · Cited by 19
Montero, J. A., Lorda-Diez, C. I., & Hurlé, J. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593761 · Cited by 15
“…mice subjected to individual deletion of the different components of this cascade (including A1, Bak, Bax, Bad, Bcl2, Bik, Bim, Bmf, Bok, Hrk, Puma, and Noxa) lack the digit phenotype and most of them develop normally (Ke et al., 2018; and reviews by Tuzlak et al., 2016; Voss and Strasser, 2020).”
BackgroundSenescent macrophages in tumor: phenotypes, roles, and interventions
Shen, W., Huang, Y., Yang, X., Zhang, Y., Pan, Y., Xiao, Y., Wang, J., Wang, C., Mao, W., & Zhao, A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08000-5 · Cited by 17
“Crystal et al. found that chemotherapy-induced senescent tumor cells acquire a survival advantage by engul fi ng neighboring cells, exhibiting gene expression changes associated with phagocytic function [36].”
Zhang, Y., Zhou, T., Li, J., Xu, N. X., Cai, M., Zhang, H., Zhao, Q., & Wang, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s270466 · Cited by 14
Clinical potential of the Hippo-YAP pathway in bladder cancer
Cheng, X., Lou, K., Ding, L., Zou, X., Huang, R., Xu, G., Zou, J., & Zhang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.925278 · Cited by 13
Mapping Cell-in-Cell Structures in Oral Squamous Cell Carcinoma
da Rocha, L. D. O. S., Souza, B. S. D. F., Coletta, R. D., Lambert, D., & Rocha, C. A. G. (2023) · Cells · doi:10.3390/cells12192418 · Cited by 14
Mirzayans, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060322 · Cited by 14
Almohaimeed, G. M., Alonazi, A. S., Dayel, A. F. B., Alshammari, T. K., Alghibiwi, H. K., Alamin, M. A., Almotairi, A. R., & Al-Rasheed, N. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040759 · Cited by 11
Ghislanzoni, S., Kang, J. W., Bresci, A., Masella, A., Kobayashi-Kirschvink, K. J., Polli, D., Bongarzone, I., & So, P. T. C. (2023) · Biosensors · doi:10.3390/bios13110973 · Cited by 11
Senescent cells feed on their neighbours
Overholtzer, M. (2019) · Nature · doi:10.1038/d41586-019-03271-3 · Cited by 11
Mirzayans, R., & Murray, D. L. (2024) · Cancers · doi:10.3390/cancers16173106 · Cited by 10
Low dose chemotherapy induces a dormant state in brain metastatic breast cancer spheroids
Kondapaneni, R. V., Warren, R., & Rao, S. S. (2022) · AIChE Journal · doi:10.1002/aic.17858 · Cited by 11
Self-citationPhosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells
Frey, W. D., Anderson, A. Y., Lee, H., Nguyen, J. B., Cowles, E., Lu, H., & Jackson, J. G. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001858 · Cited by 11
“Engulfment conferred a survival advantage [27].”
BackgroundMethodResultSelf-citationWu, T., Li, X., Ba, S., Jones, P., Hansel, D. E., & Liu, J. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217447 · Cited by 9
Could senescence phenotypes strike the balance to promote tumor dormancy?
Chiu, F.-Y., Kvadas, R. M., Mheidly, Z., Shahbandi, A., & Jackson, J. G. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10089-z · Cited by 8
“Senescent cells are arrested and have properties such as the SASP [12], phagocytosis proficiency [38, 39], autophagy [40], and others that could enable tumor cell survival for years, but also provide compelling possibilities for tumor cells’ eventual emergence from dormancy [2, 14, 41–43] via both cell autonomous and…”
BackgroundSelf-citationZhou, H., Li, C., Ren, Y., Wang, W.-A., Zhuang, J., Ren, Y., Shen, L., & Chen, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116234 · Cited by 8
Dolan, M., Shi, Y., Mastri, M., Long, M. D., McKenery, A., Hill, J. W., Vaghi, C., Benzekry, S., Barbi, J. J., & Ebos, J. M. L. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0139 · Cited by 11
Cell hiding in colorectal cancer: correlation with response to chemotherapy in vitro and in vivo
Николаевна, Д. И., Potapov, A., Ignatova, N. I., Bugrova, M. L., Shchechkin, I. D., Lukina, M. M., Shimolina, L. E., Kolesnikova, E., Shirmanova, M. V., & Вадимовна, З. Е. (2024) · Scientific Reports · doi:10.1038/s41598-024-79948-1 · Cited by 13
A 3D, Compartmental Tumor-Stromal Microenvironment Model of Patient-Derived Bone Metastasis
Garakani, M. M., Cooke, M. E., Wertheimer, M. R., Weber, M. H., Ajji, A., & Rosenzweig, D. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010160 · Cited by 6
Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer
Liu, X., & Yang, J. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1242725 · Cited by 8
“This ultimately leads to tumor persistence and poor patient survival (63).”
BackgroundTonnessen-Murray, C. A., & Jackson, J. G. (2019) · Molecular & Cellular Oncology · doi:10.1080/23723556.2019.1688601 · Cited by 6
“Interestingly, the engulfment phenotype can be induced either by ectopic p53 activation in the absence of DNA damage, or by DNA damage/chemotherapy (possibly thru SASP) in the absence of p53.(6) This built-in redundancy of the engulfment program suggests a strong selective pressure on cells that survive chemotherapy,…”
BackgroundSelf-citationYang, X., Sun, Y., Liu, X., & Jiang, Z. (2022) · Cancer Medicine · doi:10.1002/cam4.4674 · Cited by 4
Chen, Y., Zhu, Z., Ma, T., Zhang, L., Chen, J., Jiang, J., Lu, C., Ding, Y., Guan, W., Yi, N., et al. (2023) · Smart Medicine · doi:10.1002/smmd.20230005 · Cited by 6
Cannibalism in Breast Cancer: The Dangers of Overeating
Haupt, S., Keam, S. P., & Haupt, Y. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.008 · Cited by 5
Targeting Minimal Residual Disease
Chou, Y., Allegakoen, P., & Bivona, T. G. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070924-120742 · Cited by 7
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Jiang, C., & Wu, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1412296 · Cited by 4
de Mendonça, L. B., Lenz, G., & Filippi‐Chiela, E. C. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253054 · Cited by 5
Gupta, K., Koelsch, N. J., Neely, V. L., Graham, L., Bear, H. D., Idowu, M. O., Harada, H., & Manjili, M. H. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03292-y · Cited by 5
“Future efforts should prioritize the development of tumor-targeted Bcl-xL inhibitor delivery platforms to achieve safe and effective systemic treatment.”
Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer
Yin, C., Yu, J., Liu, G., He, J., & Wu, P. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155315 · Cited by 4
Cell-in-cell phenomena across the tree of life
Kapsetaki, S. E., Cisneros, L. H., & Maley, C. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-57528-7 · Cited by 5
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Lin, C., Hadfield, M. J., Rathore, A., Pinho-Schwermann, M. P., Zhang, S., Lu, S., den Hollander, P., Mani, S. A., Seyhan, A. A., Santopietro, A., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103061 · Cited by 5
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
“Interestingly, unknown properties of chemotherapy-induced senescent cells about engul fi ng neighbor non-treated cells were shown by Tonnessen-Murray et al. while performing time-lapse observation in vitro on cancer cells 4226 extracted from rats and on cell lines MCF-7 and MPE600 [63].”
BackgroundComprehensive profiling of L1 retrotransposons in mouse
Zhang, X., Celic, I., Mitchell, H., Stuckert, S., Vedula, L., & Han, J. S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae273 · Cited by 4
“Cultured 4226 cells ( 46 ) were washed with phosphate-buffered saline and stained with propidium iodide.”
MethodBeware of thy neighbor: Senescent cancer cells feast on adjacent cells to persist
Napoli, M., & Flores, E. R. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201910040 · Cited by 4
Liu, X., Shi, Q., Choudhry, N., Zhang, T., Liu, H., Zhang, S., Zhang, J., & Yang, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012104 · Cited by 4
“Some senescent cancer cells may even maintain their long-term viability by feeding on surrounding cells [20,21].”
BackgroundEditorial: Cellular senescence in physiology and pathophysiology
Ark, M., & Uddin, M. N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1173284 · Cited by 3
“An interesting study published in JCB revealed that senescent cancerous cells phagocytose both neighboring senescent and non-senescent tumor cells in their microenvironment (Tonnessen-Murray et al., 2019).”
BackgroundImmune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 6
Shazia, I., Tsui, H. Y. C., Chen, S., Li, X., Mat, W., Khan, M. A., Choy, L. B., Chan, K.-Y. A., Chan, T. M. D., Ng, C. P. S., et al. (2024) · Cell Division · doi:10.1186/s13008-024-00109-x · Cited by 3
“As indicated by earlier research, chemotherapy-induced senescent cancer cells were found to engulf other cells as a survival strategy [29, 30], and it was noted that the formation of tunneling nanotubes in MCF-7 breast cancer cells could promoted cancer cell survival against 5-fluorouracil [31].”
BackgroundAn Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202404885 · Cited by 2
The battle within: cell death by phagocytosis in cancer
Zhou, L., Fan, S., Zhang, W., Gong, Z., Wang, D., & Tang, D. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03650-x · Cited by 2
“In therapeutic oncology drug-treated breast cancer, tumor cells enter a cell cycle-delayed, senescent state, and senescent tumor cells can survive via phagocytosis by adjacent cells [54].”
Metadata
- Authors
- Tonnessen-Murray, C. A., Frey, W. D., Rao, S. G., Shahbandi, A., Ungerleider, N. A., Olayiwola, J. O., Murray, L. B., Vinson, B. T., Chrisey, D. B., Lord, C. J., & Jackson, J. G.
- Affiliations
- Tulane University (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Jackson, James G.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2019-09-17
- Volume
- 218
- Issue
- 11
- Pages
- 3827-3844
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC6829672
- OpenAlex
- W2973542731
- Cited by
- 127
- References
- 59
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 23 · 2023: 16 · 2022: 20 · 2021: 18 · 2020: 25 · 2019: 6
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH-14-1-0216)
- National Institutes of Health
- National Institute of General Medical Sciences (1P30GM114732-01, U54 GM104940)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- chemotherapy-induced senescence, senescence-associated secretory phenotype, breast cancer, p53, cell engulfment, lysosomal degradation, tumor cell survival, relapse, cytokine production, lysosomes
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Cell Survival, Doxorubicin, Humans, Tumor Cells, Cultured, Cellular Senescence, Cell Proliferation, Mice, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.